Interpace Diagnostics

Interpace Diagnostics is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States through its Commercial Services business, and developing and commercializing molecular diagnostic tests through its Interpace Diagnostics business. Interpace Diagnostics's Commercial Services is focused on providing outsourced pharmaceutical, biotechnology, medical device and diagnostic sales teams to its corporate customers. Interpace Diagnostics's Interpace Diagnostics is focused on developing and commercializing molecular diagnostic tests, leveraging the latest technology and personalized medicine for better patient diagnosis and management.




Type
Public
HQ
Parsippany-Troy Hills, US
Founded
1987
Size (employees)
775 (est)
Interpace Diagnostics was founded in 1987 and is headquartered in Parsippany-Troy Hills, US

Interpace Diagnostics Office Locations

Interpace Diagnostics has office in Parsippany-Troy Hills
Parsippany-Troy Hills, US

Interpace Diagnostics Metrics

Interpace Diagnostics Summary

Market capitalization

$5.12 M

Closing share price

$2.76
Interpace Diagnostics's current market capitalization is $5.12 M.

Interpace Diagnostics Financials

Interpace Diagnostics's revenue is $9.43 M in FY, 2015 which is 92.14% decrease from the previous period.
FY, 2015FY, 2014FY, 2013

Revenue

$9.43 M$120 M$151 M

Net Income

$-11.4 M$-16.1 M$-4.57 M

Interpace Diagnostics Market Value History

Interpace Diagnostics Online Presence

Interpace Diagnostics Company Life

You may also be interested in